Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Aubignat

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Neurology|November 18, 2025
Clarifying Order and Carry-Over Effects in Sequential MRgFUS Thalamotomy and Pallidothalamic Tract AblationMickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|November 18, 2025
Unilateral Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain TargetMickael Aubignat
Parkinsonism & Related Disorders|March 23, 2025
Concerns regarding the inclusion of a preprint in a meta-analysis on GLP-1 agonists in Parkinson's DiseaseMickael Aubignat
Movement Disorders Clinical Practice|June 9, 2026
Bridging the Gap in Isometric Tremor Assessment: Formally Classified but Clinically Ignored?Mickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2025
Does Dopamine Sensitivity Influence the Choice between Subthalamotomy and Thalamotomy for Parkinsonian Tremor?Mickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2024
Which Focused Ultrasound Thalamotomy Lesion Is Optimal for Dystonic Tremor?Mickael Aubignat
Movement Disorders Clinical Practice|January 3, 2024
Evaluating the Scope and Safety of Bilateral MRgFUS Thalamotomy for Essential Tremor: A Critical AnalysisMickael Aubignat
JAMA Neurology|January 27, 2025
Cognitive Effects of MR-Guided Focused Ultrasound Thalamotomy-Time to EvaluationMickael Aubignat, Olivier Godefroy
La Revue Du Praticien|March 19, 2021
[Hypercalcemia and bone tumors]Mickael Aubignat, Amar Smail
Movement Disorders Clinical Practice|July 11, 2024
Continuous Subcutaneous Foslevodopa-Foscarbidopa in Parkinson's Disease: A Mini-Review of Current Scope and Future OutlookMickael Aubignat, Melissa Tir
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Neurology|November 18, 2025
Clarifying Order and Carry-Over Effects in Sequential MRgFUS Thalamotomy and Pallidothalamic Tract AblationMickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|November 18, 2025
Unilateral Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Pallidothalamic Tractotomy in Parkinson's Disease: Promising Results But Uncertain TargetMickael Aubignat
Parkinsonism & Related Disorders|March 23, 2025
Concerns regarding the inclusion of a preprint in a meta-analysis on GLP-1 agonists in Parkinson's DiseaseMickael Aubignat
Movement Disorders Clinical Practice|June 9, 2026
Bridging the Gap in Isometric Tremor Assessment: Formally Classified but Clinically Ignored?Mickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|April 28, 2025
Does Dopamine Sensitivity Influence the Choice between Subthalamotomy and Thalamotomy for Parkinsonian Tremor?Mickael Aubignat
Movement Disorders : Official Journal of the Movement Disorder Society|February 28, 2024
Which Focused Ultrasound Thalamotomy Lesion Is Optimal for Dystonic Tremor?Mickael Aubignat
Movement Disorders Clinical Practice|January 3, 2024
Evaluating the Scope and Safety of Bilateral MRgFUS Thalamotomy for Essential Tremor: A Critical AnalysisMickael Aubignat
JAMA Neurology|January 27, 2025
Cognitive Effects of MR-Guided Focused Ultrasound Thalamotomy-Time to EvaluationMickael Aubignat, Olivier Godefroy
La Revue Du Praticien|March 19, 2021
[Hypercalcemia and bone tumors]Mickael Aubignat, Amar Smail
Movement Disorders Clinical Practice|July 11, 2024
Continuous Subcutaneous Foslevodopa-Foscarbidopa in Parkinson's Disease: A Mini-Review of Current Scope and Future OutlookMickael Aubignat, Melissa Tir
Pageof 3